İnsan İnsülin Hormonu Öncülerinin Pichia pastoris AOX1 Promotoru Altında Klonlanması, Ekspresyonu ve Biyoreaktörde Üretimi

İnsülin pankreasın beta hücrelerinden üretilen ve vücutta glukoz dengesini sağlayan önemli bir peptit hormondur. Pankreasın yeterli miktarda insülin üretememesi ya da hücrelerin üretilen insüline cevap verememesi sonucu kan glukoz düzeyinin yükselmesiyle diyabet adı verilen metabolik bir hastalık meydana gelir. Günümüzde bu hastalığın tedavisinde insülin hormonu kullanılmaktadır. İnsülin hormonu genetik mühendisliği teknikleri kullanılarak rekombinant olarak üretilen ilk proteindir. İlk olarak Escherichia coli ve Saccharomyces cerevisiae’da üretilmeye başlanmış, ancak son zamanlarda rekombinant insülin üretiminde Pichia pastoris (Komagataella phaffi) ’in  kullanımı yaygınlaşmıştır. Bu çalışmada, insan insülin hormonu öncülerinin (IP) P. pastoris’in metanol ile indüklenebilir AOX1 promotoru altında üretimini sağlamak amacıyla; bu proteini kodlayan DNA fragmenti transformasyon ve ligasyon gibi moleküler biyoloji teknikleri kullanılarak plazmide aktarılarak istenen proteini kodlayan bir ekspresyon vektörü elde edilmiştir. Ekspresyon vektörünün lityum asetat yöntemiyle yetenekli hale getirilen P. pastoris X33 suşuna elektroporasyonla transferi sağlanmıştır. 5L ölçekli biyoreaktörde yapılan protein ekspresyonu çalışması sonrasında alınan örnekler SDS-PAGE ve ELISA yöntemleriyle analiz edilmiş ve 7.5 mg/L IP proteini üretildiği tespit edilmiştir.

Cloning, Expression and Production in a Bioreactor of Human Insulin Precursor in Pichia pastoris under AOX1 Promoter

Insulin is a peptide hormone, produced by beta cells of the pancreas, and regulates the glucose homeostasis in the body. Diabetes mellitus is a metabolic disease in which a person has high blood sugar, either because the pancreas does not produce enough insulin, or because cells do not respond to produced insulin. At the present time, insulin is used to treatment of this disease. Insulin hormone is first protein produced recombinantly by using genetic engineering techniques. Firstly, it was produced in E. coli and Saccharomyces cerevisiae, but recently the number of studies that used Pichia pastoris (Komagataella phaffi) in the production of recombinant insulin increase. In this study, in order to produce human insulin hormone precursor (IP) under the  inducible AOX1 promoter in P. pastoris, an expression vector encoding desired protein was obtained by transferring DNA fragment coding this protein to the plasmid using molecular biology techniques such as transformation and ligation. Expression vector was transferred via electroporation to Pichia pastoris  X33 strain which rendered by lithium acetate method. After protein expression study in 5L bioreactor, obtained samples were analyzed with SDS-PAGE and ELISA methods and determined 7.5 mg/L protein produced.

___

  • [1] Brownlee, M. 2001. Biochemsitry and molecular cell biology of diabetic complications. Nature, 414, 813-820.
  • [2] Ahmad, B. 2004. Pharmacology of insülin. Br J Diabetes Vasc Dis, 4, 10-14.
  • [3] Kjeldsen, T. 2000. Yeast secretory expression of insulin precursors. Appl Microbiol Biotechnol, 54, 277-286.
  • [4] Heinemann, L., Richter, B. 1993. Clinical pharmacology of human insulin. Diabetes Care, 16(3), 90-100.
  • [5] Walsh, G. Therapeutic insulins and their large-scale manufacture. Appl Microbiol Biotechnol, 67, 151-159.
  • [6] Ferrer-Miralles, N., Domingo-Espin, J., Corchero, J.L., Vazquez, E., Villaverde, A. 2009. Microbial factories for recombinant pharmaceuticals. Microb Cell Fact, 8, 17.
  • [7] Goeddel, D.V., Kleid, D.G., Bolivar, F., Heyneker, H.L., Yansura, D.G., Crea, R., Hirose, T., Kraszewski, A., Itakura, K., Riggs, A.D. 1979. Expression in Escherichia coli of chemically synthesized genes for human insulin, Proc Natl Acad Sci USA, 76, 106-110.
  • [8] Schmidt, M., Babu, K.R., Khanna, N., Marten, S., Rinas, U. 1999. Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli. J Biotechnol, 68, 71-83.
  • [9] Thim, L., Hansen, M.T., Norris, K., Hoegh, I., Boel, E., Forstrom, J., Ammerer, G., Fiil, N.P. 1986. Secretion and processing of insulin precursors in yeast. Proc Natl Acad Sci USA, 83, 6766-6770.
  • [10] Kjeldsen, T., Brandt, J., Andersen, A.S., Egel-Mitani, M., Hach, M., Frost-Petterson, A., Vad, K. 1996. A removable spacer peptide in an 0 -factor-leader/insulin precursor fusion protein improves processing and concomitant yield of the insulin precursor in Saccharomyces cerevisiae. Gene, 170, 107-112.
  • [11] Kjeldsen, T., Frost-Petterson, A., Hach, M., Diers, I., Havelund, S., Hansen, P.H., Andersen, A.S. 1997. Synthetic leaders with potential bip binding mediate high-yield secretion of correctly folded insulin precursors from Saccharomyces cerevisiae. Protein Expression And Purification. 9, 331–336.
  • [12] Kjeldsen, T., Frost-Petterson, A., Hach, M. 1999. Secretory expression and characterization of insulin in Pichia pastoris. Biotechnol Appl Biochem. 29, 79-86.
  • [13] Wang, Y., Liang, Z.H., Zhang, Y.S., Yao, S.Y., Xu, Y.G., Tang, Y.H., Zhu, S.Q., Cui, D.F., Feng, Y.M. 2001. Human insulin from a precursor overexpressed in the methylotrophic yeast Pichia pastoris and a simple procedure for purifying the expression product. Biotechnol Bioeng. 73, 74–79.
  • [14] Pais, J.M., Varas, L., Valde´s, J., Cabello, C., Rodriguez, L., Mansur, M. 2003. Modeling of mini-proinsulin production in Pichia pastoris using the AOX promoter. Biotechnol Lett. 25, 251-255.
  • [15] Gurramkonda, C., Polez, S., Skoko, N., Adnan, A., Gabel, T., Chugh, D., Swaminathan, S., Khanna, N., Tisminetzky, S., Rinas, U. 2010. Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insülin. Microbial Cell Factories, 9(31), 1-11.
  • [16] Weydemann, U., Keup, P., Piontek, M., Strasser, A.W.M., Schweden, J., Gellissen, G., Janowicz, Z.A. 1995. High-level secretion hirudin by Hansenula polymorpha-authentic processing of three different preprohirudins. Appl Microbiol Biotechnol, 44, 377-385.
  • [17] Gellissen, G., Melber, K. 1996. Methylotrophic yeast Hansenula polymorpha as production organism for recombinant pharmaceuticals. Arzneimittelforschung, 46, 943-948.
  • [18] Raymond, C.K., Bukowski, T., Holderman, S.D., Ching, A.F.T., Vanaja, E., Stamm, M.R. 1998. Development of the Methylotrophic Yeast Pichia methanolica for the Expression of the 65 Kilodalton Isoform of Human Glutamate Decarboxylase. Yeast, 14, 11-23.
  • [19] Hagenson, M..J. 1991. Production of recombinant proteins in the methylotrophic yeast Pichia pastoris. Bioprocess Technol, 12, 193-212.
  • [20] Cregg, J.M., Vedvick, T.S., Raschke, W.C. 1993. Recent advances in the expression of foreign genes in Pichia pastoris. Bio/Technol, 11, 905–910.
  • [21] Cereghino, J.L., Cregg, J.M. 2000. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiology Reviews, 24, 45-66.
  • [22] Schagger, H., Von Jagow, G. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Analytical Biocehmistry, 166(2); 368-379.
  • [23] Pais-Chanfrau, J.M., Garcia, Y., Licor, L., Besada, V., Castellanos-Serra, L., Cabello, C.I., Hernandez, L., Mansur, M., Plana, L., Hidalgo, A., Tambara, Y., Abrahantes-Perez, M., Toro, Y., Valdes, J., Martinez, E. 2004. Improving the expression of mini-proinsulin in Pichia pastoris. Biotechnology Letters, 26, 1269-1272.
  • [24] Xie, T., Liu, Q., Xie, F., Liu, H., Zhang, Y. 2008. Secretory expression of insulin precursor in Pichia pastoris and simple procedure for producing recombinant human insulin. Preparative Biochemistry & Biotechnology, 38, 308-317.
  • [25] Annibali, N. 2006. Expression of a human insulin precursor in P. Pastoris. United States Patent, Patent No: US 7,091,032 B2.
  • [26] Annibali, N., Goin, M., Trejo, G., Carrizo, F., Baruque, D., Morales, A. 2011. Process for obtaining aspart insulin using a pichia pastoris yeast strain,United States Patent Application Publication, Pub No: US/2011/0117600.